| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/05/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 1.6k | $18.00 | $28.9k | | 10/05/2023 |
| 03/23/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 465 | $12.15 | $5.6k | | 03/21/2023 |
| 03/22/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 529 | $12.64 | $6.7k | | 03/21/2023 |
| 03/21/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 519 | $12.89 | $6.7k | | 03/21/2023 |
| 03/20/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 530 | $12.61 | $6.7k | | 03/17/2023 |
| 03/17/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 504 | $13.28 | $6.7k | | 03/17/2023 |
| 03/16/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 499 | $13.43 | $6.7k | | 03/15/2023 |
| 03/15/2023 | Tarsus Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 7.5k | $0.00 | $0 | | 03/15/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 45.5k | $15.00 | $681.9k | | 03/08/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 30.8k | $0.00 | $0 | | 03/08/2023 |